JNJ · Johnson & Johnson
United States · RS rating 75 · As of 2026-10-14
| Price | 253.91 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 37 / 71 / 84 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 45 / 40 |
| Industry group (rank) | Medical-Diversified (32) |
| EPS growth Q/Q | -0.9% |
| Sales growth Q/Q | +2.4% |
| Distance from 52-week high | +8.8% |
| Market cap (USD) | $555.2B |